5-HT2C receptor agonist

From WikiMD's Food, Medicine & Wellness Encyclopedia

5-HT2C Receptor Agonist[edit | edit source]

5-HT2C_receptor_pathway A 5-HT2C receptor agonist is a type of drug that activates the 5-HT2C receptor. The 5-HT2C receptor is a subtype of the 5-HT receptor which is directly responsive to the neurotransmitter serotonin.

Mechanism of Action[edit | edit source]

5-HT2C receptor agonists work by mimicking the action of serotonin at the 5-HT2C receptor. This results in increased activity of the receptor, which can lead to a variety of physiological effects. The exact effects depend on the specific drug and the area of the brain in which it is acting.

Therapeutic Uses[edit | edit source]

5-HT2C receptor agonists have potential therapeutic uses in a variety of conditions. These include obesity, schizophrenia, depression, and drug addiction. Some 5-HT2C receptor agonists are also used in the treatment of migraines and anxiety disorders.

Examples[edit | edit source]

Some examples of 5-HT2C receptor agonists include Lorcaserin, which is used for weight loss, and Agomelatine, which is used for the treatment of major depressive disorder.

Side Effects[edit | edit source]

Like all drugs, 5-HT2C receptor agonists can have side effects. These can include nausea, dizziness, and sleep disturbances. However, the side effects can vary greatly depending on the specific drug and the individual taking it.

See Also[edit | edit source]

References[edit | edit source]

5-HT2C receptor agonist Resources
Doctor showing form.jpg
Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.